Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Retatrutide: Early research suggests up to 2024% weight loss in some participants, making it one of the most promising emerging medications
contact your clinic if you see signs of infection or swelling that worsens after a few days
Accepted: March 20, 2021
Joint tissue resilience
Taking anti-ageing pills or injections while fasting can be risky, especially on an empty stomach
Retatrutide (LY3437943) is a single peptide engineered to agonise three incretin-family receptors at once: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR) 26
US$ 22.48
US$ 22.96
US$ 20.02
